The combination of anti-GITR therapy with radiation (55 days), or the combination of anti-GITR with anti-PD1 (70 days), delayed primary and secondary tumor growth to a greater extent than did anti-PD1 alone (24 days), but ultimately did not produce complete responses. This evidence concerns the gene TNFRSF18 and neoplasm.